It’s a new cancer treatment that genetically alters a person’s immune system, training healthy cells to target and kill deadly cancer cells. On today’s show, hear from the team of doctors who worked collaboratively in translating basic science research into successful clinical application. And later, hear from the Wisconsin man whose life has been extended after becoming the first person in the world to receive this groundbreaking treatment in a clinical trial.
Learn about the success of Dual-Target CAR-T cell therapy, inside this edition of CTSI Discovery Radio!
Parameswaran Hari, MD, Chief, Division of Hematology & Oncology, Department of Medicine, FMCW; Armand J. Quick/William F. Stapp Professor of Hematology, MCW
Nirav Shah, MD, MS, Assistant Professor of Medicine, Division of Hematology & Oncology, MCW
Bryon Johnson, PhD, Director, Bone Marrow & Transplant (BMT) Laboratories, Professor of Pediatrics, Division of Hematology, Oncology & Transplantation, MCW
David Margolis, MD, Program Director, Bone Marrow & Transplant (BMT) Program, CHW; Professor of Pediatrics, MCW
Sarah Longenecker, Research Program Manager II, All of Wisconsin Research Program, MCW
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
